Europe — EMA
Cimzia (Certolizumab Pegol)
Cimzia (Certolizumab Pegol) is a subcutaneous medication used to manage inflammatory conditions. Learn about its uses, effects, and precautions for informed hea
Request sourcing
What is Certolizumab Pegol?
Cimzia (Certolizumab Pegol) is a subcutaneous medication used to manage inflammatory conditions. Learn about its uses, effects, and precautions for informed healthcare decisions.
What is Certolizumab Pegol used for?
Cimzia is primarily used to treat inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis. It works by targeting specific proteins in the body to reduce inflammation and alleviate symptoms. People often ask, 'What is Cimzia used for?' and the answer includes managing pain and improving mobility in these conditions.
What are the side effects of Certolizumab Pegol?
Common effects of Cimzia may include injection site reactions, upper respiratory infections, and mild gastrointestinal issues. Some users report fatigue or headaches. These effects vary and are not experienced by everyone.
What precautions apply to Certolizumab Pegol?
Cimzia should be used with caution in individuals with a history of infections or allergies. It is important to follow healthcare provider instructions and monitor for any adverse reactions. Always store and handle the medication as directed.
What does Certolizumab Pegol interact with?
Cimzia may interact with other medications, including those that affect the immune system. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain supplements may also influence its effects.
